Merck & Co. Inc. buy Scotiabank
Start price
14.11.25
/
50%
€78.80
Target price
14.11.26
-
Performance (%)
65.74%
Price
21.08.26
€130.60
Summary
This prediction is currently active. The BUY prediction by Scotiabank for Merck & Co. Inc. has seen massive gains of 65.74%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 8.621% | 8.621% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by Scotiabank for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat

